Effect of bevacizumab plus double dose icotinib on advanced non-small cell lung cancer with EGFR L858R mutation. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract ...
Cobimetinib Plus Vemurafenib in Patients With Colorectal Cancer With BRAF Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study We divided the borrowing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results